A reasonable chance it could cause serious harm or death.
Crystallization: customer complaints for crystallization in finished product.
| Brand name | ACYCLOVIR |
| Generic name | ACYCLOVIR |
| Active ingredient(s) | ACYCLOVIR SODIUM |
| Distributed by / for | Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534 |
| NDC | 68382-049-01 |
| Full product label | Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | USA Nationwide |
| Quantity | 816 packs |
| Recall initiated | 2021-02-18 |
| Report date | 2021-04-07 |
| Recall completed | 2022-11-23 |
| Recall number | D-0315-2021 |
| Classification | Class I |
| FDA status | Terminated |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗